abstract |
The present invention provides a novel bis-pyridylpyridone, an antagonist of melanin-concentrating hormone receptor 1 (MCHR1), pharmaceutical compositions containing them, methods for their preparation, and treatment regimens, and for the treatment of obesity and / or diabetes. For their use. |